Hoedemaker, Niels
15  Ergebnisse:
Personensuche X
?
1

Procedural and clinical outcomes after use of the glycoprot..:

Harskamp, Ralf E. ; Hoedemaker, Niels ; Newby, L. Kristin...
Cardiovascular Revascularization Medicine.  17 (2016)  1 - p. 19-23 , 2016
 
?
2

Early intravenous beta-blockers in patients undergoing prim..:

Hoedemaker, Niels PG ; Roolvink, Vincent ; de Winter, Robbert J...
European Heart Journal. Acute Cardiovascular Care.  9 (2020)  5 - p. 469-477 , 2020
 
?
 
?
4

Trends in optimal medical therapy prescription and mortalit..:

Hoedemaker, Niels P G ; Damman, Peter ; Ottervanger, Jan Paul...
European Heart Journal - Cardiovascular Pharmacotherapy.  4 (2018)  2 - p. 102-110 , 2018
 
?
5

Trends in cardiovascular and bleeding outcomes in acute cor..:

Hoedemaker, Niels P G ; Damman, Peter ; Ottervanger, Jan Paul...
European Heart Journal - Cardiovascular Pharmacotherapy.  5 (2018)  3 - p. 127-138 , 2018
 
?
6

Early Invasive Versus Selective Strategy for Non–ST-Segment..:

Hoedemaker, Niels P.G. ; Damman, Peter ; Woudstra, Pier...
Journal of the American College of Cardiology.  69 (2017)  15 - p. 1883-1893 , 2017
 
?
7

Procedural and clinical outcomes after use of the glycoprot..:

Harskamp, R. E ; Hoedemaker, Niels ; Newby, L. K...
Harskamp , R E , Hoedemaker , N , Newby , L K , Woudstra , P , Grundeken , M J , Beijk , M A , Tijssen , J G , Mehta , R H & de Winter , R J 2016 , ' Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions ' , Cardiovasc. Revascularization Med. , vol. 17 , pp. 19-23 . https://doi.org/10.1016/j.carrev.2015.09.005.  , 2016
 
?
9

Optimal Medical Therapy Prescription in Patients with Acute..:

Hoedemaker, Niels P. G ; de Winter, Robbert J ; Hof, Arnoud van't..
Hoedemaker , N P G , de Winter , R J , Hof , A V , Kolkman , E & Damman , P 2021 , ' Optimal Medical Therapy Prescription in Patients with Acute Coronary Syndrome in the Netherlands : A Multicenter Pilot Registry ' , American Journal of Cardiovascular Drugs , vol. 21 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s40256-020-00427-9.  , 2021
 
?
11

Early intravenous beta-blockers in patients undergoing prim..:

Hoedemaker, Niels P. G ; Roolvink, Vincent ; de Winter, Robbert J...
Hoedemaker , N P G , Roolvink , V , de Winter , R J , van Royen , N , Fuster , V , Garcia-Ruiz , J M , Er , F , Gassanov , N , Hanada , K , Okumura , K , Ibanez , B , van 't Hof , A W & Damman , P 2020 , ' Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction : A patient-pooled meta-analysis of randomized clinical trials ' , European Heart Journal: Acute Cardiovascular Care , vol. 9 , no. 5 , pp. 469-477 . https://doi.org/10.1177/2048872619830609.  , 2020
 
?
12

Trends in optimal medical therapy prescription and mortalit..:

Hoedemaker, Niels P. G ; Damman, Peter ; Ottervanger, Jan Paul...
Hoedemaker , N P G , Damman , P , Ottervanger , J P , Dambrink , J H E , Gosselink , A T M , Kedhi , E , Kolkman , E , de Winter , R J & van 't Hof , A J 2018 , ' Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome : a 9-year experience in a real-world setting ' , European Heart Journal-Cardiovascular Pharmacotherapy , vol. 4 , no. 2 , pp. 102-110 . https://doi.org/10.1093/ehjcvp/pvy005.  , 2018
 
1-15